We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Automated System Introduced for Blood Fractionation in Biobanking Applications

By LabMedica International staff writers
Posted on 22 Jan 2013
A fully automated workstation was launched for blood fractionation in biobanking applications. It effectively eliminates error-prone manual pipetting steps and increases the safety of biobanking samples with state-of-the-art imaging technology, excellent pipetting capabilities, and powerful sample tracking software.

The easyBlood STARlet workstation was introduced at the annual Society of Laboratory Automation and Screening meeting in January 2013. The system is a high-throughput, fully integrated workstation that enables technicians to reliably pipette the desired layer of primary blood samples, including the buffy coat. Compatible with laboratory information management systems (LIMS), it offers full traceability by ensuring that data can be linked confidently to each sample, and enables an efficient biobanking workflow.

The easyBlood STARlet system is manufactured by Hamilton (Bonaduz, Switzerland) and is based on the compact Hamilton Robotics Microlab STARlet platform. The Hamilton STAR line of instruments offers laboratories flexibility in liquid handling application design, including heating and cooling devices, multichannel heads, and HEPA hoods. The easyBlood STARlet workstation offers customers the ability to fractionate blood from a multitude of primary sample tubes to a variety of 2D-barcoded and storage-ready target containers found in today’s biobanks.

The comprehensive easyBlood STARlet system includes all required components and software for reading and loading barcoded, decapped samples, and additional labware such as plates and pipette tips. The instrument's high-resolution, camera-based fraction identification detects difficult targets, such as buffy coats and gel separators in centrifuged samples. The system provides complete control and monitoring of the pipetting process with software-enabled adjustment of pipetting speed to suit specific liquid classes. All three fractions (plasma, buffy coat, and erythrocytes) are pipetted and aliquoted as desired.

The easyBlood workstation also integrates with the new, -80 °C BiOS third-generation automated storage system, which was designed for sample integrity and superior service.

Related Links:
Hamilton

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Biological Indicator Vials
BI-O.K.
New
Silver Member
Verification Panels for Assay Development & QC
Seroconversion Panels
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.